CANF · Can-Fite BioPharma Ltd.
Market Cap
$7.28M
Shares
2.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-17 | — | |
| 6-K | 2026-08-12 | — | |
| 6-K | 2026-08-03 | — | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-06 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-06-04 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-04-30 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-03-30 | — | |
| 20-F | 2026-03-26 | 2025-12-31 | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-17 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-03-04 | — | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2026-02-09 | — | |
| 6-K | 2026-02-05 | — | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2026-01-20 | — | |
| 6-K | 2026-01-16 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-16 | — | |
| 6-K | 2025-11-21 | — | |
| 6-K | 2025-11-20 | — | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-10-03 | — | |
| 6-K | 2025-09-15 | — | |
| 6-K | 2025-08-28 | 2025-06-30 | |
| 6-K | 2025-07-30 | — | |
| 6-K | 2025-07-29 | — | |
| 6-K | 2025-07-28 | — | |
| 6-K | 2025-07-28 | — | |
| 6-K | 2025-06-30 | — | |
| 6-K | 2025-06-23 | — | |
| 6-K | 2025-06-16 | — | |
| 6-K | 2025-05-16 | — |
Showing 1–50 of 274 filings